Therapy: HAMLET takes a leading role on the colorectal cancer stage

Nature Reviews Gastroenterology and Hepatology

Volumn 10, Issue 3, 2013, Pages 126-

  Smith, Katherine ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; APC PROTEIN; BETA CATENIN; HUMAN ALPHA LACTALBUMIN MADE LETHAL TO TUMOR CELL; UNCLASSIFIED DRUG; WNT PROTEIN;

ANTINEOPLASTIC ACTIVITY; BLADDER CANCER; CANCER CELL; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER MORTALITY; CANCER PREVENTION; CANCER STAGING; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; COLON CANCER; COLORECTAL CANCER; DRUG EFFICACY; GENE EXPRESSION REGULATION; HEREDITARY COLORECTAL CANCER; HUMAN; LOSS OF FUNCTION MUTATION; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SKIN PAPILLOMA; TUMOR SUPPRESSOR GENE; UPREGULATION;

EID: 84875217620     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2013.27     Document Type: Note

References (1)

1. Puthia, M. et al. Prevention and treatment of colon cancer by peroral administration of HAMLET (human a-lactalbumin made lethal to tumour cells). Gut doi.10.1136/gutjnl-2012-303715